This November 19th story has been corrected to state that 60% of Americans have been fully vaccinated.

Manas Mishra and Michael Erman

(Reuters) – U.S. regulators extended eligibility for COVID-19 booster vaccines to all adults Friday. This allowed millions of Americans additional protection from the virus in light of a recent increase in infection rates.

Rochelle Wilensky, the director of Centers for Disease Control and Prevention signed off Friday evening on expanded eligibility. This was after the U.S. Food and Drug Administration widened authorization for booster doses for all adults who received their second shot, either Pfizer/BioNTech, or both. Moderna (NASDAQ) Inc vaccine at minimum six months earlier

Regulators had previously authorized boosters for all recipients of Johnson & Johnson (NYSE:)’s one-dose vaccine, two months after their primary dose.

“Booster shots have demonstrated the ability to safely increase people’s protection against infection and severe outcomes and are an important public health tool to strengthen our defenses against the virus as we enter the winter holidays,” Walensky said in a statement.

According to CDC data, while most adults are already eligible for additional shots, less than 18% have received them. Many officials in public health felt that previous eligibility requirements were excessively complicated.

The current guidelines, though thoughtful and well-intentioned, create a barrier to booster uptake. “In pursuit of precision they create confusion,” Nirav Shaikh, top Maine official in public health and president of Association of State and Territorial Health Officials, said.

Shah stated that Shah was concerned about the fact that not all eligible people are receiving boosters at this time.

An agency spokesperson said the CDC did not say that all adults need to get a booster. Individuals can choose to get the vaccine, according to the agency for people aged between 18-49.

The CDC has also clarified recommendations for individuals aged 50 to 64. It suggests that all people in this age bracket should be boosted, not only those suffering from underlying conditions.

Guidelines for the agency mirrored earlier recommendations by a panel CDC advisors.

SECTION CASES ON RISE

Following two months of decreasing infections, the United States reports daily rises in infection rates over the last two weeks. These are due to an easier-to-transmit Delta strain of the virus as well as people staying indoors because it is colder.

Eric Topol is the Scripps Research Translational Institute director in La Jolla (California). He said that guidance was not sufficient to promote booster doses.

Topol stated that the United States may face an unprecedented number of COVID-19-related cases in this winter. And, protection is now diminishing.

He stated, “We’re just sitting ducks”.

The nation’s top infectious disease expert, Dr. Anthony Fauci, said this week https://www.reuters.com/world/us/fauci-says-us-can-reach-covid-endemic-level-rather-than-pandemic-next-year-2021-11-16 that boosters, along with increasing overall vaccination, should help the country move beyond the worst of the pandemic in the coming months.

FDA stated that data from studies using both Moderna and Pfizer/BioNTech vaccines showed that the third shot increased immune response to the virus.

Scientists remain worried about the rare instances of inflammation that may occur in young men after vaccination, especially for Moderna vaccine recipients. According to Israeli data, the incidence of inflammation in the heart after a third dose was higher than that following the first. Pfizer (NYSE:) The cost of the vaccine is much lower after two doses.

Biden’s administration offered boosters to all in August. But, as experts disagreed with the idea of further vaccinations in all age groups, it made them available only in phases.

Over 32 million Americans received boosters. They were authorized for those who have an immunocompromise, 65 years and older, as well as for people with severe health problems, such obesity or being regularly exposed through their work and living situations.

Nearly 60% of Americans are considered fully vaccinated, having received two doses of either the Pfizer/BioNTech or Moderna vaccines, or one shot of J&J’s vaccine.